Success Metrics

Clinical Success Rate
100.0%

Based on 7 completed trials

Completion Rate
100%(7/7)
Active Trials
0(0%)
Results Posted
71%(5 trials)

Phase Distribution

Ph phase_3
4
50%
Ph phase_1
2
25%
Ph phase_2
1
13%

Phase Distribution

2

Early Stage

1

Mid Stage

4

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
2(28.6%)
Phase 2Efficacy & side effects
1(14.3%)
Phase 3Large-scale testing
4(57.1%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

7 of 7 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

0

trials recruiting

Total Trials

8

all time

Status Distribution
Completed(7)
Other(1)

Detailed Status

Completed7
unknown1

Development Timeline

Analytics

Development Status

Total Trials
8
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 12 (28.6%)
Phase 21 (14.3%)
Phase 34 (57.1%)

Trials by Status

unknown113%
completed788%

Recent Activity

0 active trials
Showing 5 of 8
completedphase_3

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

NCT04078126
completed

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

NCT03114969
completedphase_1

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

NCT03073057
unknownphase_2

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients

NCT02093195
completedphase_3

Study to Investigate the Efficacy of Symbicort® SMART.

NCT00839800
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT04078126Phase 3

Study Comparing Dual Combination of Product (Budesonide and Formoterol) Given Via Two Different Inhalers. To See Which One Results in the Best Effect on Breathing.

Completed
NCT03114969

Comparative Study of Error Rates Between ELLIPTA® Dry Powder Inhaler (DPI) and Other DPIs

Completed
NCT03073057Phase 1

Pharmacokinetic Study to Compare Absorption of Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler

Completed
NCT02093195Phase 2

Study of Bosentan in the Treatment of Stable Severe Chronic Obstructive Pulmonary Disease Patients

Unknown
NCT00839800Phase 3

Study to Investigate the Efficacy of Symbicort® SMART.

Completed
NCT01627158Phase 1

Pharmacokinetic Study Comparing Budesonide/Formoterol Easyhaler and Symbicort Turbuhaler Forte

Completed
NCT00837967Phase 3

Study to Investigate the Safety and Efficacy of High Dose of Symbicort® SMART in Japanese Patients

Completed
NCT00536731Phase 3

Symbicort Rapihaler Therapeutic Equivalence Study

Completed

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8